Heparin suppresses cyclosporine-induced endothelin-1 synthesis in rat endothelial cells

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Yokokawa, Koji ^a   Kohno, Masakazu ^a   Minami, Mieko ^a   Yasunari, Kenichi ^a   Mandal, Anil K ^b   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Cyclosporine; Endothelin; Endothelium; Heparin; Nitric oxide

Indexed keywords

ANTICOAGULANT AGENT; CALMODULIN; CYCLOSPORIN; ENDOTHELIN 1; ENZYME INHIBITOR; HEPARIN; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMICAL PHENOMENA; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NORTHERN BLOTTING; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; ANTICOAGULANTS; AORTA, THORACIC; BLOTTING, NORTHERN; CALMODULIN; CELLS, CULTURED; CYCLOSPORINE; DEPRESSION, CHEMICAL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEPARIN; IMMUNOSUPPRESSIVE AGENTS; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0031630450     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00131     Document Type: Article

References (30)

1. Cohen DJ, Loertscher R, Rubin MF, et al. Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 1984;101:667-82.
2. Ozdigan E, Banner N, Fitzgerald M, et al. Factors influencing the development of hypertension after heart transplantation. J Heart Transplant 1990;9:548-53.
3. Curtis JJ. Cyclosporine and posttransplant hypertension. J Am Soc Nephrol 1992;2:S243-5.
4. Luke RG. Essential hypertension: a renal disease? A review and update of the evidence. Hypertension 1993;21:380-90.
5. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
6. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487-91.
7. Bunchman TE, Brookshire CA. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991; 88:310-4.
8. Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arteries. J Clin Invest 1993;91:2144-9.
9. Fogo A, Hellings SE, Inagami T, Kon V. Endothelin receptor antagonist is prospective in vivo acute cyclosporine toxicity. Kidney Int 1992;42:440-774.
10. Perico N, Dadan J, Remuzzi G. Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol 1990;1:76-83.
11. Benatti L, Bonecchi L, Cozzi L, Sarmientos R. Two preproendothelin-1 mRNAs transcribed by alternative promoters. J Clin Invest 1993;91:1149-56.
12. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 1991;84:1457-68.
13. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
14. Palmar RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
15. Sakuma I, Stuehr DJ, Gross SS, et al. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:8664-7.
16. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587-90.
17. Yokokawa K, Mandal AK, Kohno M, et al. Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats. Am J Physiol 1992;263:R1035-41.
18. Imai T, Hirata Y, Emori T, Marumo F. Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells. Hypertension 1993;21:353-8.
19. Yokokawa K, Tahara H, Kohno M, et al. Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Cell Invest 1993;92:2080-5.
20. Susic D, Mandal AK, Kentera D. Heparin lowers in blood pressure in hypertensive rats. Hypertension 1982;4:681-5.
21. Wilson SK, Solez K, Boitnott J, Heptinstall RH. The effect of heparin treatment on hypertension and vascular lesions in stroke-prone spontaneously hypertensive rats. Am J Physiol 1981;102:62-71.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;17:1309-20.
23. Sakurai T, Yanagisawa M, Inoue A, et al. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun 1991;175:44-7.
24. Benigni A, Morigi M, Perico N, et al. The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 1992;54:775-80.
25. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporine-induced endothelial cell injury. Lab Invest 1986;55: 455-62.
26. Lau DCW, Wong K, Hwang WS. Cyclosporine toxicity on cultured rat microvascular endothelial cells. Kidney Int 1989;35:604-13.
27. Komas N, Lugnier C, Stoclet JC. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 1991;104:495-503.
28. Castellot JJ, Pukac LA, Caleb BL, Wright TC, Karnovsky MJ. Heparin selectively inhibits a protein kinase C dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol 1989;109:3147-56.
29. Kohno M, Yokokawa K, Horio T, et al. Heparin inhibits endothelin-1 production in cultured rat mesangial cells. Kidney Int 1994; 45:37-42.
30. Murohara T, Parkinson SJ, Waldman, et al. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. Arterioscler Thromb Vasc Biol 1995;15: 2068-75.